- Home
- RAPT vs OKYO Comparison
RAPT vs OKYO Comparison
Compare RAPT & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- OKYO
- Stock Information
- Founded
- RAPT 2015
- OKYO 2007
- Country
- RAPT United States
- OKYO United Kingdom
- Employees
- RAPT N/A
- OKYO N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RAPT Health Care
- OKYO Health Care
- Exchange
- RAPT Nasdaq
- OKYO Nasdaq
- Market Cap
- RAPT 122.9M
- OKYO 105.5M
- IPO Year
- RAPT 2019
- OKYO 2022
- Fundamental
- Price
- RAPT $13.31
- OKYO $2.75
- Analyst Decision
- RAPT Buy
- OKYO Strong Buy
- Analyst Count
- RAPT 5
- OKYO 1
- Target Price
- RAPT $36.75
- OKYO $7.00
- AVG Volume (30 Days)
- RAPT 133.4K
- OKYO 145.3K
- Earning Date
- RAPT 08-07-2025
- OKYO 08-12-2025
- Dividend Yield
- RAPT N/A
- OKYO N/A
- EPS Growth
- RAPT N/A
- OKYO N/A
- EPS
- RAPT N/A
- OKYO N/A
- Revenue
- RAPT N/A
- OKYO N/A
- Revenue This Year
- RAPT N/A
- OKYO N/A
- Revenue Next Year
- RAPT N/A
- OKYO N/A
- P/E Ratio
- RAPT N/A
- OKYO N/A
- Revenue Growth
- RAPT N/A
- OKYO N/A
- 52 Week Low
- RAPT $5.67
- OKYO $0.81
- 52 Week High
- RAPT $27.84
- OKYO $3.11
- Technical
- Relative Strength Index (RSI)
- RAPT 69.39
- OKYO 54.08
- Support Level
- RAPT $10.00
- OKYO $2.67
- Resistance Level
- RAPT $14.09
- OKYO $2.85
- Average True Range (ATR)
- RAPT 1.04
- OKYO 0.24
- MACD
- RAPT 0.42
- OKYO -0.04
- Stochastic Oscillator
- RAPT 87.32
- OKYO 46.15
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.